Join
Live feed
·
NEWSReleasevia Quantisnow
OSR Holdings Inc. logo

Vaximm AG, an OSR Company, Announces Forthcoming Publication of Cross-Indication Clinical Data for VXM01, Its VEGFR-2-Targeted Cancer Vaccine Platform

ByQuantisnow·Wall Street's wire, on your screen.
OSRH· OSR Holdings Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OSRH (OSR Holdings Inc.) and more on Quantisnow.